References
- Thompson JR, Woodruff G, Hiscox FA, Strong N, Minshull C. The incidence and prevalence of amblyopia detected in childhood. Public Health 1991;105(6):455–462.
- Tomilla V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol 1981;65(8):575–577.
- Rahi JS, Logan S, Timms C et al. Risk, causes and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 2002;360(9333):597–602.
- Information services. http://www.gov.uk Accessed August 2015.
- Adams GG, Karas MP. Effect of amblyopia on employment prospects. Br J Ophthalmol 1999;83:380.
- Rahi JS, Cumberland PM, Peckham CS. Does amblyopia affect educational, health, and social outcomes? Findings from 1958 British birth cohort. BMJ 2006;332(7545):820–825.
- Grant S, Conway M. Reach-to-precision grasp deficits in amblyopia: effects of object contrast and low visibility. Vision Res 2015;114;100–110.
- Hall DMB. Screening for vision defects. In: Hall DM, Elliman D, eds. Health for All Children, 4th ed. Oxford, England: Oxford Medical Publications, 2003, 230–244.
- Donahue SP, Ruben JB; American Academy of Ophthalmology; American Academy of Pediatrics, Ophthalmology Section; American Association for Pediatric Ophthalmology and Strabismus; Children’s Eye Foundation; American Association of Certified Orthoptists. US Preventive Services Task Force vision screening recommendations. Pediatrics 2011;127(3):569–570.
- Benchmarking data for vision screening in the UK. https://orthoptics.org.uk/visionscreening. Accessed August 2015.
- Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol 2002;86(8):915–919.
- Deprivation data. UK Data Service website. http://census.ukdataservice.ac.uk/get-data/related/deprivation.aspx. Accessed September 2015.
- Clarke MP. Review of amblyopia treatment: are we over treating children with amblyopia? Br Ir Orthopt J 2010;7:3–7.
- Hospital episode statistics. Health & Social Care Information Centre website. http://www.hesonline.nhs.uk. Accessed March 2015.
- Stewart CE, Moseley MJ, Fielder AR, Stephens DA; on behalf of the MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2004;88(12):1552–1556.
- Hertle RW, Scheiman MM, Beck RW, Chandler DL, Bacal DA, Birch E, Chu RH, Holmes JM, Klimek DL, Lee KA, Repka MX, Weakley DR Jr; Pediatric Eye Disease Investigator Group. Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years. Arch Ophthalmol 2007;125:655–659.
- Pediatric Eye Disease Investigator Group. A randomised trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120(3):268–278.
- Holmes JM, Kraker RT, Beck RW, et al; Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003;110(11):2075–2087.
- Scheiman MM, Hertle RW, Kraker RT, et al; Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol 2008;126(12):1634–1642.
- Pediatric Eye Disease Investigator Group (PEDIG) Writing Committee, Wallace DK, Kraker RT, et al. Randomized trial to evaluate combined patching and atropine for residual amblyopia. Arch Ophthalmol 2011;129(7):960–962.
- Repka MX, Kraker RT, Beck RW, et al. Treatment of severe amblyopia with atropine: results from 2 randomized clinical trials. J AAPOS 2009;13(5):258–263.
- Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 2004;45(9):3048–3054.
- Newsham D. The effect of recent amblyopia research on current practice in the UK. Br J Ophthalmol 2010;94(10):1352–1357.